Seroepidemiology And Co- Infections of Hepatitis D Virus Infection In The North- East of Iran

Hosseini, SeydMousalreza and Esmaeilzadeh, Abbas and Mokhtarifar, Ali and Sima, Hamid reza and Vosughi, Hasan and Saadatnia, Hasan and Khosravi, Ahmad (2010) Seroepidemiology And Co- Infections of Hepatitis D Virus Infection In The North- East of Iran. medical journal of mashhad university of medical sciences, 53 (2). pp. 69-72.

[img]
Preview
Text
MJMS_Volume 53_Issue 2_Pages 69-72.pdf

Download (141kB) | Preview
Official URL: http://mjms.mums.ac.ir/article_5386.html

Abstract

Introduction HBV infection is the most common cause of chronic hepatitis in Iran. HDV prevalence in chronic carriers of HBV has not been studied in the north-east of Iran. This study evaluated the prevalence, risk factors and co-infections of HDV with HCV. Materials and Methods This cross-sectional study was carried out From Sep Oct 2004 to Sep Oct 2005. The patients divided into two groups, inactive chronic carrier and chronic liver disease (chronic hepatitis and/or liver cirrhosis). Our study included 350 chronic HBV carriers in whom we assessed HDV Ab by ELISA method, then HDV Ab positive patients were assessed for risk factors and Co-infections with HCV. Later risk factors and co-infections were compared in HDV positive and HDV negative patients. Results Analysis of serum markers indicated that 10 (35/350) of patients had evidence of HDV infection; Anti-HDV was found in 4.5 (7/153) of patients with inactive carriers, and in 14.2 (28/197) of patients with chronic liver disease (chronic hepatitis and/or cirrhosis). Main risk factors of HDV positive and HDV negative infections included positive family history, blood transfusion, which were almost equal in two groups (p> 0.5). One out of thirty five (2.8) of HDV positive patients showed triple infection of HBV/HDV/HCV. Also, 2.8 (1/35) of HDV negative patients showed dual infection of HBV/HCV Conclusion The present study shows that HDV infection is prevalent in the north-east of Iran, particularly in chronic hepatitis and cirrhosis, and it should be studied in them. Routine assessment of HCV in these patients is not recommended, unless risk factors exist.

Item Type: Article
Subjects: WA Public Health
Divisions: Journals > Medical J Mashhad University of Medical Sciences
Depositing User: mjmums mjmums
Date Deposited: 03 Oct 2017 18:13
Last Modified: 03 Oct 2017 18:13
URI: http://eprints.mums.ac.ir/id/eprint/7496

Actions (login required)

View Item View Item